Skip to main content
Funded Studies

Kalle Gehring, PhD

Professor at McGill University

Location: Montreal Canada

Kalle Gehring, PhD, is a professor of biochemistry at McGill University, Montreal, Canada. His laboratory uses biophysical methods to study proteins involved in neurodegenerative diseases with a focus on the link between neurodegeneration, mitochondria and the ubiquitin system. He has been studying Parkin since 2007 and has published peer-reviewed studies on its structure, activity and involvement in Parkinson’s disease. He founded the Quebec/Eastern Canada Regional NMR Centre and the McGill Centre for Structural Biology. He is also part of PROTEO, a Quebec Network for Research on Protein Function, Engineering, and Applications. Dr. Gehring earned his doctorate from the University of California, Berkeley. His papers in Science and the Nature Structural Molecular Biology have garnered considerable attention with invitations to present at Cold Spring Harbor Laboratory, EMBO and Keystone Symposia meetings.

Associated Grants

  • Shoring Up a Medical Chemistry Approach to Treating Parkinson’s Disease: The Bridge Initiative


  • Structural Insights into Activated Intermediates of Parkin Continued


  • Conformational Changes in the Activation of the Ubiquitin Ligase Parkin


  • Structural Insights into Activated Intermediates of Parkin


We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.